Ulrich H. Weidle

8.1k total citations
160 papers, 6.7k citations indexed

About

Ulrich H. Weidle is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ulrich H. Weidle has authored 160 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 68 papers in Cancer Research and 50 papers in Oncology. Recurrent topics in Ulrich H. Weidle's work include Protease and Inhibitor Mechanisms (32 papers), MicroRNA in disease regulation (26 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). Ulrich H. Weidle is often cited by papers focused on Protease and Inhibitor Mechanisms (32 papers), MicroRNA in disease regulation (26 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). Ulrich H. Weidle collaborates with scholars based in Germany, Switzerland and Netherlands. Ulrich H. Weidle's co-authors include Fabian Birzele, Goos N.P. van Muijen, Stefan Klostermann, Ulrich Brinkmann, Rüdiger Rüger, Hannes Stockinger, Daniela Eggle, Guido W.M. Swart, Georg Tiefenthaler and D. J. Ruiter and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Ulrich H. Weidle

158 papers receiving 6.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrich H. Weidle Germany 48 3.9k 2.3k 2.0k 1.1k 924 160 6.7k
Marie‐Pierre Chenard France 38 2.7k 0.7× 2.5k 1.1× 2.8k 1.4× 948 0.9× 756 0.8× 137 6.9k
Jasti S. Rao United States 54 4.4k 1.1× 3.8k 1.6× 2.4k 1.2× 641 0.6× 1.2k 1.3× 169 8.3k
Michael Ploug Denmark 55 3.1k 0.8× 4.7k 2.0× 2.2k 1.1× 964 0.9× 1.4k 1.5× 157 8.8k
Alicia G. Arroyo Spain 41 1.8k 0.5× 1.5k 0.6× 1.2k 0.6× 1.2k 1.0× 1.7k 1.9× 74 5.0k
Clare M. Isacke United Kingdom 57 4.9k 1.2× 1.8k 0.8× 2.5k 1.3× 1.2k 1.1× 1.3k 1.4× 141 8.5k
Viktor Magdolen Germany 46 3.0k 0.8× 2.6k 1.1× 2.0k 1.0× 477 0.4× 890 1.0× 202 6.4k
Georgina S. Butler Canada 38 2.5k 0.6× 3.5k 1.5× 2.6k 1.3× 791 0.7× 940 1.0× 58 6.7k
Masabumi Shibuya Japan 41 4.6k 1.2× 1.2k 0.5× 1.7k 0.8× 990 0.9× 472 0.5× 77 6.6k
Thórdur Óskarsson Germany 26 3.9k 1.0× 2.6k 1.1× 3.1k 1.6× 1.2k 1.1× 433 0.5× 39 7.3k
Gunilla Høyer‐Hansen Denmark 48 2.2k 0.6× 3.5k 1.5× 2.1k 1.1× 797 0.7× 1.2k 1.3× 149 6.3k

Countries citing papers authored by Ulrich H. Weidle

Since Specialization
Citations

This map shows the geographic impact of Ulrich H. Weidle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich H. Weidle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich H. Weidle more than expected).

Fields of papers citing papers by Ulrich H. Weidle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich H. Weidle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich H. Weidle. The network helps show where Ulrich H. Weidle may publish in the future.

Co-authorship network of co-authors of Ulrich H. Weidle

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich H. Weidle. A scholar is included among the top collaborators of Ulrich H. Weidle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich H. Weidle. Ulrich H. Weidle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weidle, Ulrich H. & Adam Nopora. (2024). CircRNAs in Pancreatic Cancer: New Tools for Target Identification and Therapeutic Intervention. Cancer Genomics & Proteomics. 21(4). 327–349. 2 indexed citations
2.
Weidle, Ulrich H., Hung‐En Hsia, & Ulrich Brinkmann. (2023). Breast Cancer: Circular RNAs Mediating Efficacy in PreclinicalIn VivoModels. Cancer Genomics & Proteomics. 20(3). 222–238. 5 indexed citations
3.
Weidle, Ulrich H. & Adam Nopora. (2023). Up-regulated Circular RNAs in Colorectal Cancer: New Entities for Therapy and Tools for Identification of Therapeutic Targets. Cancer Genomics & Proteomics. 20(2). 132–153. 5 indexed citations
4.
Weidle, Ulrich H. & Adam Nopora. (2021). MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets. Cancer Genomics & Proteomics. 18(5). 591–603. 1 indexed citations
5.
Weidle, Ulrich H., et al.. (2021). Gastric Cancer: Identification of microRNAs Inhibiting Druggable Targets and Mediating Efficacy in PreclinicalIn VivoModels. Cancer Genomics & Proteomics. 18(4). 497–514. 2 indexed citations
6.
Weidle, Ulrich H., et al.. (2020). microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models. Cancer Genomics & Proteomics. 17(5). 453–468. 4 indexed citations
7.
Weidle, Ulrich H., Fabian Birzele, & Adam Nopora. (2019). Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models. Cancer Genomics & Proteomics. 16(6). 451–464. 17 indexed citations
8.
Weidle, Ulrich H., et al.. (2018). Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis. Cancer Genomics & Proteomics. 15(1). 1–15. 26 indexed citations
9.
Weidle, Ulrich H., Ina Rohwedder, Fabian Birzele, Elisabeth H. Weiss, & Christian Schiller. (2018). LST1: A multifunctional gene encoded in the MHC class III region. Immunobiology. 223(11). 699–708. 6 indexed citations
10.
Weidle, Ulrich H., Jens Niewöhner, & Georg Tiefenthaler. (2016). The Blood-Brain Barrier Challenge for the Treatment of Brain Cancer, Secondary Brain Metastases, and Neurological Diseases.. PubMed. 12(4). 167–77. 57 indexed citations
11.
Weidle, Ulrich H., Guy Georges, & Ulrich Brinkmann. (2012). Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizon.. PubMed. 9(3). 119–33. 21 indexed citations
12.
Weidle, Ulrich H., et al.. (2003). The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways. Experimental Cell Research. 283(1). 80–90. 16 indexed citations
13.
Hildebrandt, Tobias, et al.. (2000). Identification of THW, a putative new tumor suppressor gene.. PubMed. 20(5A). 2801–9. 20 indexed citations
14.
Hildebrandt, Tobias, Stefan Klostermann, Sepp Kaul, et al.. (1999). Identification of URIM, a novel gene up-regulated in metastasis.. PubMed. 19(1A). 525–30. 4 indexed citations
15.
Remacle, Albert G., Eugenia N. Baramova, Ulrich H. Weidle, H. W. Krell, & J.M. Foidart. (1995). Purification of Progelatinases A and B by Continuous-Elution Electrophoresis. Protein Expression and Purification. 6(4). 417–422. 9 indexed citations
16.
Weidle, Ulrich H.. (1994). Studies on functional and structural role of urokinase receptor and other components of the plasminogen activation system of malignancy:. TNO Repository. 1 indexed citations
17.
Kaluza, Brigitte, Helmut Lenz, Hanno Hock, et al.. (1991). Synthesis and functional characterization of a recombinant monoclonal antibody directed against the α-chain of the human interleukin-2 recept. Gene. 107(2). 297–305. 9 indexed citations
18.
Weissenhorn, Winfríed, et al.. (1991). Chimerization of antibodies by isolation of rearranged genomic variable regions by the polymerase chain reaction. Gene. 106(2). 273–277. 9 indexed citations
19.
Weidle, Ulrich H., Peter Buckel, & Ralf Mattes. (1988). A protease-hypersensitive deletion derivative of human tissue-type plasminogen activator. Gene. 73(2). 439–447. 6 indexed citations
20.
Weidle, Ulrich H. & Peter Buckel. (1987). Establishment of stable mouse myeloma cells constitutively secreting human tissue-type plasminogen activator. Gene. 57(1). 131–141. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Pierre Chenard Breakdown of academic impact, for papers by Jasti S. Rao Breakdown of academic impact, for papers by Michael Ploug Breakdown of academic impact, for papers by Alicia G. Arroyo Breakdown of academic impact, for papers by Clare M. Isacke Breakdown of academic impact, for papers by Viktor Magdolen Breakdown of academic impact, for papers by Georgina S. Butler Breakdown of academic impact, for papers by Masabumi Shibuya Breakdown of academic impact, for papers by Thórdur Óskarsson Breakdown of academic impact, for papers by Gunilla Høyer‐Hansen
Rankless by CCL
2026